Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Assets (2016 - 2025)

Voyager Therapeutics' Return on Assets history spans 11 years, with the latest figure at 0.44% for Q4 2025.

  • For Q4 2025, Return on Assets fell 28.0% year-over-year to 0.44%; the TTM value through Dec 2025 reached 0.44%, down 28.0%, while the annual FY2025 figure was 0.37%, 20.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.44% at Voyager Therapeutics, down from 0.42% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.41% in Q4 2023 and bottomed at 0.52% in Q3 2021.
  • The 5-year median for Return on Assets is 0.13% (2022), against an average of 0.1%.
  • The largest annual shift saw Return on Assets plummeted -66bps in 2021 before it surged 73bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.39% in 2021, then skyrocketed by 31bps to 0.27% in 2022, then surged by 251bps to 0.41% in 2023, then plummeted by -139bps to 0.16% in 2024, then tumbled by -179bps to 0.44% in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Return on Assets are 0.44% (Q4 2025), 0.42% (Q3 2025), and 0.32% (Q2 2025).